<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Metformin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Metformin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Endocrine / Metabolic / Antidotes</div>
      <h1>Metformin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Metformin 500mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Note:</strong> Metformin is typically stocked for continuation therapy in known diabetics aboard ship; initiation of new metformin therapy should be provider-directed.</p>
        <ul>
          <li><strong>Type 2 diabetes mellitus (continuation therapy)</strong>
            <ul>
              <li>Continue patient's established dose (common maintenance doses range from 500 mg once daily to 1000 mg twice daily)</li>
              <li>Maximum dose: 2000–2550 mg/day (divided doses), but follow patient's home regimen</li>
            </ul>
          </li>
          <li><strong>If initiating therapy onboard (provider-directed only)</strong>
            <ul>
              <li>Start 500 mg PO once or twice daily with meals</li>
              <li>Titrate slowly (every 1–2 weeks) to minimize GI side effects; follow medical direction</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Type 2 diabetes mellitus (first-line oral agent when appropriate)</li>
          <li>Continuation therapy for patients with established diabetes already on metformin</li>
          <li>Off-label: polycystic ovary syndrome (PCOS), prediabetes prevention (provider-directed)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li><strong>Contraindicated:</strong> significant renal impairment (eGFR &lt;30 mL/min/1.73m²; use caution if &lt;45); metabolic acidosis; acute/unstable heart failure</li>
          <li><strong>Lactic acidosis risk:</strong> hold during acute illness with dehydration, sepsis, hypoxia, or shock</li>
          <li>Hold before and for 48 hours after iodinated contrast studies (risk of contrast-induced nephropathy → lactic acidosis)</li>
          <li>Excessive alcohol intake increases lactic acidosis risk</li>
          <li>Caution in hepatic impairment; avoid in severe liver disease</li>
          <li>Vitamin B12 deficiency: long-term use may reduce B12 absorption (monitor if feasible)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (nausea, diarrhea, abdominal discomfort) – common, especially at initiation; often improves with dose titration and taking with food</li>
          <li>Metallic taste</li>
          <li>Lactic acidosis (rare but serious; risk increased in renal impairment, acute illness, dehydration)</li>
          <li>Hypoglycemia risk is low when used alone (but increases with insulin or sulfonylureas)</li>
          <li>Vitamin B12 deficiency (long-term use)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Take with meals to reduce GI side effects</li>
          <li>Swallow tablets whole with water; do not crush extended-release formulations (if onboard)</li>
          <li>Maintain adequate hydration</li>
          <li>Hold during acute illness (vomiting, diarrhea, dehydration) and restart only when stable and eating/drinking normally</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Blood glucose (if glucometer available onboard): target fasting ~4–7 mmol/L, postprandial &lt;10 mmol/L per guidelines</li>
          <li>Symptoms of hyperglycemia (polyuria, polydipsia, fatigue) and hypoglycemia (shakiness, sweating, confusion)</li>
          <li>GI side effects; if severe/persistent diarrhea or vomiting, hold metformin and reassess</li>
          <li>Signs of lactic acidosis (rare): unexplained hyperventilation, severe fatigue, muscle pain, abdominal pain; stop metformin and seek urgent care</li>
          <li>Renal function (if labs available): ensure eGFR adequate before continuing therapy</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Primarily a continuation medication; verify patient's home dose and recent glucose control/renal function if possible</li>
          <li>If patient becomes acutely unwell (vomiting, dehydration, infection, sepsis), hold metformin until stable to reduce lactic acidosis risk</li>
          <li>Limited lab capability: be conservative; if renal function unknown and patient is older/at risk, consider medical consultation</li>
          <li>Document blood glucose readings when available to assess control and guide ongoing management</li>
          <li>Ensure patient has adequate supply for voyage duration; arrange resupply or medical evacuation if medication runs out</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (metformin): <a href="https://pdf.hres.ca/dpd_pm/00062241.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00062241.PDF</a></li>
          <li>Diabetes Canada Clinical Practice Guidelines: <a href="https://guidelines.diabetes.ca/" target="_blank" rel="noopener">https://guidelines.diabetes.ca/</a></li>
          <li>Medscape drug reference (metformin): <a href="https://reference.medscape.com/drug/glucophage-metformin-342778" target="_blank" rel="noopener">https://reference.medscape.com/drug/glucophage-metformin-342778</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
